Sanofi-aventis’s core strategy for growth – Alliance, mergers and acquisitions 22 June 2011 / By merrylyn yeo / Partnering & Investment, Reports / 2 comments
A*STAR’s formula to fostering world-class scientific research 20 June 2011 / By merrylyn yeo / Drug Discovery, Reports / 0 comments
BioPharma Asia Convention 2011 is tomorrow! 28 March 2011 / By merrylyn yeo / Uncategorized / 0 comments
Developing countries need Orphan Drugs 16 February 2011 / By merrylyn yeo / Orphan Drugs / 0 comments
Remain germ-free to become more active? 7 February 2011 / By merrylyn yeo / Drug Discovery / 0 comments
Speeding up drug discovery leadtimes 13 December 2010 / By merrylyn yeo / Drug Discovery / 0 comments
Biocon to invest $161M in Malaysia 11 November 2010 / By merrylyn yeo / Partnering & Investment / 0 comments
Local markets are booming in Asia – Who are the top Asian companies? 8 November 2010 / By merrylyn yeo / Clinical Trials / 0 comments
Top 3 challenges that are holding back Asia’s biopharma industry 26 October 2010 / By merrylyn yeo / Partnering & Investment / 0 comments
